Clinical TrialsSearch results
Number of results: 610
Other
- Observational Registry:Gastrointestinal Complications developed during low-dose aspirin intake or atherothrombosis such as myocardial infarction and cerebral infarction-
- Cerebral infarction, TIA, angina, myocardial infarction, atrial fibrillation
- Society for the MAGIC
- 2007-07-01
Other
- Japan Thrombosis Registry for Atrial fibrillation, Coronary (Myocardial Infarction) or Cerebrovascular (Cerebral Infarction / Cerebral hemorrhage) Events
- stroke, myocardial infarction, atrial fibrillation
- Society for the J-TRACE
- 2005-10-01
Recruiting
- Uric acid Reduction Ameliorates Transition to End-stage renal disease Study (URATE Study)
- hyperuricemia chronic kidney disease (CKD)
- Society for Research on chronic kidney disease and hyperuricemia
- 2008-12-15
Recruiting
- Non-inferiority testing of bisphosphonates versus activated VitD plus bisphosphonate monotherapy for glucocorticoid-induced osteoporosis
- glucocorticoid-induced osteoporosis
- Shunsuke Furuta
- 2022-02-05
Other
- Adjuvant Chemotherapy for colon cancer with HIgh EVidencE in high-risk stage II (JFMC48-1301-C4: ACHIEVE-2 Trial)
- high-risk stage II colon cancer (including rectosigmoid cancer)
- Shitara Kohei
- 2019-02-18
Other
- A phase 2 multicenter study evaluating the safety and efficacy of Nilotinib in patients with Imatinib-resistant/intolerant Ph+CML in chronic phase
- Chronic myelogenous leukemia
- Shimousa Hematology Study Group
- 2009-06-01
Completed
- Imagery rescripting for Chronic Pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-03-25
Recruiting
- Rsecue in cogunitive behavioral family therapy
- somatic symtom disorder with predominant pain
- Shimizu Eiji
- 2021-08-16
Recruiting
- cognitive behaviolral familly therapy for chronic pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-02-09
Recruiting
- JCOG2110: a randomized trial for OLIGo metastases breast cAncer with or without Metastasis-dIrected therapy
- Advanced breast cancer with 3 or fewer oligo metastases
- Shien Tadahiko
- 2023-11-08